Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Gina Voitov

Physician Assistant, Surgical Columbus, OH Physician Assistant

NPI 1043663024 CMS profile 10506053

3555 Olentangy River Rd Ste 2001, Columbus, OH 43214

Open in the dashboard

General payments

$2,465

66 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gina Voitov of Columbus, OH is reported in the CMS Open Payments database as having received $2,465 across 66 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $413 11
2024 General $465 17
2023 General $452 12
2022 General $910 18
2021 General $226 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gina Voitov
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Gina Voitov were reported at $413. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Gina Voitov Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $226 $111 $36–$285 $132
2022 $910 $126 $44–$350 $149
2023 $452 $137 $47–$355 $160
2024 $465 $146 $49–$384 $164
2025 $413 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. DePuy Synthes Sales Inc. $919 34 payments
  2. SI-BONE, Inc. $447 5 payments
  3. Boston Scientific Corporation $230 3 payments
  4. Route 92 Medical, Inc. $174 2 payments
  5. Stryker Corporation $131 2 payments
  6. Globus Medical, Inc. $129 5 payments
  7. Djo, LLC $116 2 payments
  8. Orthofix Medical, Inc. $86 5 payments
  9. LeMaitre Vascular, Inc. $62 3 payments
  10. 4WEB, Inc. $47 1 payment
  11. Other $126 4 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,465 66 payments
Products named General payments · program years 2021–2025
  1. FIBERGRAFT BG Morsels $290 9 payments
  2. SYMPHONY $221 9 payments
  3. Expedium VERSE $140 4 payments
  4. GENERAL PAIN MANAGEMENT $131 2 payments
  5. CMF $116 2 payments
  6. General - Pain Management $99 1 payment
  7. VIPER $71 4 payments
  8. CAPRI CORPECTOMY CAGE SYSTEM $69 1 payment
  9. YUKON OCT SPINAL SYSTEM $69 1 payment
  10. X-PAC $68 2 payments
  11. Other $761 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

430

Median for Physician Assistant: 241

Drug cost

$3,723

Median for Physician Assistant: $4,110

Branded share of claims

10.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 115 $1,365
Methocarbamol Generic 69 $689
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 45 $543
Celecoxib Generic 15 $227
Mupirocin Generic 22 $167
Meloxicam Generic 49 $147
Oxycodone Hcl Generic 20 $137
Tramadol Hcl Generic 27 $131
Diclofenac Sodium Generic 14 $113
Prednisone Generic 29 $103

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$34,501

Medicare's payments for the services billed

Medicare patients

267

Average age 78

Services billed

407

146 women, 121 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Ischemic heart disease 41%
Depression 38%
Diabetes 32%
Atrial fibrillation 29%
Chronic kidney disease 26%
Cancer 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

66 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record